Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or Without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant Francesco d'Amore , Sirpa Leppa , Maria Gomes da Silva , Thomas Relander , Grete Fossum Lauritzsen , Peter De Nully Brown , Antonio Pezzutto , Jeanette K. Doorduijn , Eckhart Weidmann , Michel van Gelder , Achiel Van Hoof , Ilse Christiansen , Unn Merete Fagerli , Hans Hagberg , P. J. Lugtenburg , Jan Walewski , Ka Lung Wu , Hilde Maria Demuynck , Rob Fijnheer , Jacob H. Christensen , Milada Jankovska , Par L. Josefsson , Hanneke Kluin-Nelemans , Jose Mario Mariz , Mats A. Merup , Thomas Noesslinger , Eric Van den Neste , Josee M. Zijlstra , Georg Hopfinger , V. I. T. Prochazka , Esa Jantunen , Ludmila Boudova , Jose Cabecadas , Andreas Chott , Jan M. A. Delabie , Laurence de Leval , Arjan Diepstra , Marja-Liisa Karjalainen-Lindsberg , Peter Noergaard , Andreas Rosenwald , Grzegorz Rymkiewicz , Christer Sundstrom , Lorenz Truemper , Gerald Wulf , Lauren Chong , Alyssa Bouska , Lynette Smith , Christian Gisselbrecht , Marita Ziepert , Markus Loeffler , Knut Liestol , Christian Steidl , Randy D. Gascoyne , David W. Scott , Bettina Altmann , Javeed Iqbal , Wing C. Chan , Helle Toldbod Blood（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
